$62.52 +0.54 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Mar. 30, 2015 | 04:00 PM

Partner Headlines

  1. Insys Therapeutics Q4 beats

    IBD | Mar. 3, 2015 | 18:32PM EST
  2. Insys Therapeutics Q4 Beat Drives Short-Lived Rally

    IBD | Mar. 3, 2015 | 11:46AM EST
  3. Teva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary Endpoints

    Benzinga | Feb. 24, 2015 | 09:04AM EST
  4. Stocks Hitting 52-Week Highs

    Benzinga | Feb. 17, 2015 | 10:09AM EST
  5. Morning Market Gainers

    Benzinga | Feb. 17, 2015 | 09:43AM EST
  6. Three Reasons To Let Akorn Fall Into Your Portfolio

    IBD | Feb. 6, 2015 | 11:11AM EST
  7. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  8. Stocks Rise In Weak Trade; LinkedIn Jumps After Hours

    IBD | Feb. 5, 2015 | 17:03PM EST
  9. Stocks Close Near Session Highs, But Volume Softens

    IBD | Feb. 5, 2015 | 16:18PM EST
  10. Opko Health And Teva Pharmaceutical Industries Surge Following Chairman's Resignation

    Benzinga | Feb. 5, 2015 | 11:54AM EST
  11. Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals

    GuruFocus | Feb. 4, 2015 | 14:39PM EST
  12. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD | Jan. 28, 2015 | 15:35PM EST
  13. Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium

    Benzinga | Jan. 27, 2015 | 09:33AM EST
  14. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  15. Teva Pharmaceutical

    IBD | Jan. 20, 2015 | 18:45PM EST
  16. Sterne Agee Analyst: Court Win To Boost Net At Teva Pharmaceutical

    Benzinga | Jan. 20, 2015 | 15:50PM EST
  17. Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks

    Benzinga | Jan. 20, 2015 | 13:00PM EST
  18. US Stock Futures Slip Ahead Of Home Price, Consumer Confidence Data

    Benzinga | Dec. 30, 2014 | 07:10AM EST
  19. OncoGenex to Regain Rights to Custirsen from Teva

    Benzinga | Dec. 30, 2014 | 07:03AM EST
  20. United Therapeutics: Will It Pass Peers In 2015?

    IBD | Dec. 12, 2014 | 18:11PM EST
  21. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  22. UPDATE: Sterne Agee Upgrades Teva Pharmaceutical

    Benzinga | Dec. 12, 2014 | 09:12AM EST
  23. Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition

    Benzinga | Dec. 11, 2014 | 08:36AM EST
  24. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  25. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus | Dec. 8, 2014 | 10:16AM EST
  26. Why Opko Health Is a Better Investment Than Apple

    GuruFocus | Dec. 2, 2014 | 13:01PM EST
  27. Benzinga's M&A Chatter for Tuesday November 18, 2014

    Benzinga | Nov. 18, 2014 | 19:34PM EST
  28. Here Are The Top 25 Analysts On Wall Street

    Benzinga | Nov. 13, 2014 | 10:47AM EST
  29. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD | Nov. 11, 2014 | 11:33AM EST
  30. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

    Benzinga | Oct. 31, 2014 | 16:54PM EST
  31. Teva ups full-year EPS outlook

    IBD | Oct. 30, 2014 | 19:14PM EST
  32. UPDATE: Teva Posts Stronger-Than-Expected Q3 Profit, Lifts Forecast

    Benzinga | Oct. 30, 2014 | 08:21AM EST
  33. Earnings Scheduled For October 30, 2014

    Benzinga | Oct. 30, 2014 | 05:12AM EST
  34. Lannett Co. Gets Growth Rx In Generic Drugs Group

    IBD | Oct. 27, 2014 | 17:59PM EST
  35. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD | Oct. 13, 2014 | 16:33PM EST
  36. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

    Benzinga | Oct. 13, 2014 | 05:22AM EST
  37. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  38. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  39. Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects Possible for Divestment, Discontinuation

    Benzinga | Oct. 6, 2014 | 08:35AM EST
  40. Fast Money Halftime Report Final Trade From October 2 - Twitter Inc, McDonald's Corporation And More

    Benzinga | Oct. 3, 2014 | 07:15AM EST
  41. Insys Therapeutics Up On Bullish Analyst Initiation

    IBD | Oct. 2, 2014 | 12:03PM EST
  42. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca

    Benzinga | Sep. 3, 2014 | 05:10AM EST
  43. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  44. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga | Aug. 15, 2014 | 07:23AM EST
  45. Jana Partners LLC Files its 13F

    Benzinga | Aug. 14, 2014 | 15:54PM EST
  46. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield

    Benzinga | Aug. 11, 2014 | 05:20AM EST
  47. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  48. Did George Soros Sell His Stake In Israeli Based SodaStream Due To Political Reasons?

    Benzinga | Aug. 4, 2014 | 15:10PM EST
  49. 5 Drug Companies Profiting From Generics

    Benzinga | Aug. 4, 2014 | 08:29AM EST
  50. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD | Jul. 28, 2014 | 18:49PM EST
Trading Center